ROYAL BANK OF CANADA - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 24 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 9.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2021$3,0001,000
+24900.0%
0.00%
Q1 2017$0
-100.0%
4
-99.9%
0.00%
Q3 2015$24,000
+2300.0%
3,250
+5227.9%
0.00%
Q2 2014$1,000610.00%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
BVF INC/IL 1,347,755$574,8180.02%
Virtu Financial LLC 31,633$130.00%
Western Wealth Management, LLC 29,537$12,5970.00%
Belpointe Asset Management LLC 14,050$5,9920.00%
TSFG, LLC 3,000$10.00%
ZRC WEALTH MANAGEMENT, LLC 100$430.00%
Allworth Financial LP 250$1070.00%
JANE STREET GROUP, LLC 13,189$5,6250.00%
RAYMOND JAMES & ASSOCIATES 138,040$58,8740.00%
BOURGEON CAPITAL MANAGEMENT LLC 500$2140.00%
View complete list of GALMED PHARMACEUTICALS LTD shareholders